Food and Drug Administration FDA

Dog food recalled over salmonella risk

Hosted on MSN · 1d

FDA Changes Raise Concerns About Food Recalls

The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.

Staten Island Advance · 1d

Dog food recalled over salmonella risk: Here’s what the FDA wants you to know

Blue Ridge Beef is recalling 5,700 pounds of its 2-pound log Natural Mix, according to the FDA, which warned that salmonella can affect animals, and there is risk to humans from handling the food, especially if they have not thoroughly washed their hands after having contact with the product or any surfaces exposed to the it.

Forbes · 1d

Class 1 Recalls & Food Safety—Why They’re More Common Than You Think

Class 1 recalls pose serious health risks, from undeclared allergens to bacterial contamination. Here’s how Class 1 recalls work, plus major FDA food recalls in 2025.

FDA labels broccoli sold at Walmart

NJ.com · 16h

Broccoli recall: FDA upgrades recall to ‘deadliest level’ for florets sold at Walmart in 20 states, throw out ASAP

The recall announced in January involves contaminated broccoli sold in 20 states. Here's everything you need to know

USA Today · 1d

FDA labels broccoli sold at Walmart as deadly. See where it was sold and what you should do

The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the agency.

6abc News · 14h

Recalled broccoli sold at Walmart labeled potentially deadly by FDA

Braga Fresh Foods initially issued a voluntary recall for one lot of its 12-ounce bags of Marketside Broccoli Florets on Dec. 27, 2024, according to the original company announcement shared by the FDA on Dec. 31, 2024.

Acrivon Therapeutics, FDA and Breakthrough Device

Business Insider · 17h

Acrivon Therapeutics:FDA Grants Breakthrough Device Designation For ACR-368 OncoSignature Assay

Wednesday, announced that the FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay for the treatment of endometrial cancer. The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing,

MarketWatch · 20h

Acrivon Therapeutics Gets FDA Breakthrough Device Designation for Cancer Identification

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of endometrial cancer patients who may benefit from ACR-368 treatment.

Investing.com on MSN · 18h

ACR-368 OncoSignature assay gains FDA breakthrough status

Acrivon Therapeutics, Inc. (NASDAQ: ACRV), a clinical stage biopharmaceutical company with a market capitalization of $184 million and an impressive 60% stock return over the past year, announced that its ACR-368 OncoSignature assay has received Breakthrough Device designation from the U.

9hon MSN

FDA Assigns Highest Risk Level To These Recalled Chocolate Snacks

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

1don MSN

U.S. FDA approves Supernus' drug-device combination for Parkinson's disease

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

HealthDay on MSN1h

FDA Approves Symbravo for Acute Treatment of Migraine in Adults

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

The Washington Post9d

Americans might finally have to face what’s in their food

(Scott Olson/Getty Images) In the final days of the Biden administration, the Food and Drug Administration proposed ... including the FDA and the Centers for Disease Control and Prevention ...

WTKR1d

Sell by, use by, or best by? The FDA wants to know when you throw away food

The FDA says millions of tons of food is wasted every year and now they want to better understand how you feel about ...

Business Wire1d

FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results